Arrowgrass Capital Partners (US)’s Avista Healthcare Public Acquisition Corp. Warrants AHPAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-646,500
Closed -$129K 337
2018
Q3
$129K Sell
646,500
-250,000
-28% -$72.2K ﹤0.01% 198
2018
Q2
$834K Hold
896,500
0.03% 183
2018
Q1
$296K Hold
896,500
0.01% 125
2017
Q4
$502K Sell
896,500
-603,500
-40% -$214K ﹤0.01% 460
2017
Q3
$600K Buy
+1,500,000
New +$630K ﹤0.01% 513

Arrowgrass Capital Partners (US)'s AHPAW Position: Q4 2018 in Review

Arrowgrass Capital Partners (US) sold out of Avista Healthcare Public Acquisition Corp. Warrants (AHPAW) in Q4 2018, closing a stake of 646,500 shares — an estimated $129K sold.

Arrowgrass Capital Partners (US) first reported a position in AHPAW in Q3 2017 and held it in 5 quarters. The position peaked at $834K in Q2 2018. 0 funds tracked by Wall St. Rank hold AHPAW as of Q4 2018.

  • Arrowgrass Capital Partners (US) reported no remaining Avista Healthcare Public Acquisition Corp. Warrants position as of Q4 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 646,500 Avista Healthcare Public Acquisition Corp. Warrants shares in Q4 2018, an estimated $129K.
  • Arrowgrass Capital Partners (US) first reported a position in Avista Healthcare Public Acquisition Corp. Warrants in Q3 2017 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s Avista Healthcare Public Acquisition Corp. Warrants position peaked at $834K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Avista Healthcare Public Acquisition Corp. Warrants as of Q4 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2018, filed 14 Feb 2019.